- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cytogen's ProstaScint wins FDA nod
The Food and Drug Administration has granted Cytogen of Princeton,NJ, a license to market its ProstaScint monoclonal antibody agentfor prostate cancer imaging. Cytogen plans to have ProstaScinton the market by early next year. ProstaScint is licensed
The Food and Drug Administration has granted Cytogen of Princeton,NJ, a license to market its ProstaScint monoclonal antibody agentfor prostate cancer imaging. Cytogen plans to have ProstaScinton the market by early next year.
ProstaScint is licensed for two indications: to image newlydiagnosed patients whose biopsy-proven prostate cancer is at highrisk of metastasizing to pelvic lymph nodes, and for post-prostatectomypatients in whom there is a suspicion of cancer recurrence.
Cytogen has licensed ProstaScint rights for the urologicalmarket to C.R. Bard's urologic division, while Cytogen will retainrights to the medical imaging market (SCAN 8/28/96).
Cytogen is hoping that ProstaScint will prove to be more successfulthan its OncoScint CR/OV product for imaging colorectal and ovariancancer. The company plans to support ProstaScint through its Partnersin Excellence program, which is designed to help ensure that nuclearmedicine physicians are reading monoclonal antibody scans correctly(SCAN 9/25/96).
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
